Daniel L. Marks
Affiliations: | 2008-2013 | Pediatric Endocrinology | Oregon Health&Science University, Portland, OR, United States |
Google:
"Daniel Marks"Mean distance: 18.15 (cluster 11)
Children
Sign in to add trainee| Tetiana Korzun | grad student | 2021- | OHSU (Chemistry Tree) |
| Aaron J Grossberg | grad student | 2011 | OHSU |
| Kristianna Weymann | grad student | 2008-2013 | Oregon Health&Science University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhu X, Olson B, Keith D, et al. (2024) GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. Translational Oncology. 50: 102129 |
| Korzun T, Moses AS, Jozic A, et al. (2024) Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis. Acs Nano |
| Vermehren-Schmaedick A, Joshi S, Wagoner W, et al. (2024) Grb7 ablation in mice improved glycemic control, enhanced insulin signaling and increased abdominal fat mass in females. Endocrinology |
| Diba P, Sattler AL, Korzun T, et al. (2023) Unraveling the lost balance: Adrenergic dysfunction in cancer cachexia. Autonomic Neuroscience : Basic & Clinical. 251: 103136 |
| Park Y, Korzun T, Moses AS, et al. (2023) Targeted Nanocarriers for Systemic Delivery of IRAK4 Inhibitors to Inflamed Tissues. Small (Weinheim An Der Bergstrasse, Germany). e2306270 |
| Korzun T, Moses AS, Diba P, et al. (2023) From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics. Pharmaceuticals (Basel, Switzerland). 16 |
| Korzun T, Moses AS, Diba P, et al. (2023) Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers. Small (Weinheim An Der Bergstrasse, Germany). e2301776 |
| Korzun T, Moses AS, Kim J, et al. (2022) Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small (Weinheim An Der Bergstrasse, Germany). e2204436 |
| Gunesch AN, Sutton TL, Krasnow SM, et al. (2022) Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer. American Journal of Surgery |
| Huisman C, Norgard MA, Levasseur PR, et al. (2022) Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing. Molecular Metabolism. 101441 |